Dana Investment Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-138,114
| Closed | -$8.16M | – | 540 |
|
|
2024
Q2 | $8.16M | Buy |
138,114
+1,385
| +1% | +$86.6K | 0.28% | 99 |
|
|
2024
Q1 | $10.9M | Sell |
136,729
-13,741
| -9% | -$1.05M | 0.36% | 77 |
|
|
2023
Q4 | $11.9M | Sell |
150,470
-17,940
| -11% | -$1.28M | 0.57% | 53 |
|
|
2023
Q3 | $11.8M | Buy |
168,410
+3,639
| +2% | +$258K | 0.6% | 55 |
|
|
2023
Q2 | $11.4M | Buy |
164,771
+19,724
| +14% | +$1.4M | 0.56% | 62 |
|
|
2023
Q1 | $10.8M | Sell |
145,047
-153,910
| -51% | -$12.9M | 0.55% | 59 |
|
|
2022
Q4 | $27.9M | Buy |
298,957
+590
| +0.2% | +$56.9K | 1.46% | 10 |
|
|
2022
Q3 | $28.5M | Sell |
298,367
-34,198
| -10% | -$3.39M | 1.61% | 8 |
|
|
2022
Q2 | $30.8M | Sell |
332,565
-23,800
| -7% | -$2.32M | 1.56% | 8 |
|
|
2022
Q1 | $36.1M | Sell |
356,365
-37,246
| -9% | -$3.91M | 1.66% | 6 |
|
|
2021
Q4 | $40.6M | Sell |
393,611
-22,190
| -5% | -$2.05M | 1.76% | 6 |
|
|
2021
Q3 | $35.3M | Sell |
415,801
-3,523
| -0.8% | -$295K | 1.6% | 13 |
|
|
2021
Q2 | $35M | Buy |
419,324
+10,631
| +3% | +$871K | 1.55% | 12 |
|
|
2021
Q1 | $30.7M | Buy |
408,693
+253,865
| +164% | +$18.5M | 1.42% | 16 |
|
|
2020
Q4 | $10.6M | Sell |
154,828
-9,101
| -6% | -$592K | 0.52% | 64 |
|
|
2020
Q3 | $9.57M | Buy |
163,929
+6,626
| +4% | +$412K | 0.52% | 66 |
|
|
2020
Q2 | $10.2M | Buy |
157,303
+4,243
| +3% | +$267K | 0.55% | 66 |
|
|
2020
Q1 | $9.08M | Buy |
153,060
+30,186
| +25% | +$2.02M | 0.55% | 60 |
|
|
2019
Q4 | $9.13M | Sell |
122,874
-8,602
| -7% | -$604K | 0.44% | 71 |
|
|
2019
Q3 | $8.29M | Sell |
131,476
-305,155
| -70% | -$18.1M | 0.42% | 72 |
|
|
2019
Q2 | $23.8M | Sell |
436,631
-63,768
| -13% | -$3.43M | 1.18% | 34 |
|
|
2019
Q1 | $27M | Buy |
500,399
+183,263
| +58% | +$11.3M | 1.27% | 29 |
|
|
2018
Q4 | $20.8M | Buy |
317,136
+112,588
| +55% | +$8.4M | 1.06% | 37 |
|
|
2018
Q3 | $16.1M | Buy |
204,548
+50,139
| +32% | +$3.58M | 0.66% | 57 |
|
|
2018
Q2 | $9.94M | Buy |
+154,409
| New | +$10.2M | 0.44% | 71 |
|
|
2017
Q3 | – | Sell |
-3,152
| Closed | -$254K | – | 267 |
|
|
2017
Q2 | $254K | Sell |
3,152
-37,490
| -92% | -$2.96M | 0.01% | 258 |
|
|
2017
Q1 | $3.19M | Sell |
40,642
-27,713
| -41% | -$2.21M | 0.15% | 111 |
|
|
2016
Q4 | $5.39M | Sell |
68,355
-11,536
| -14% | -$933K | 0.25% | 101 |
|
|
2016
Q3 | $7.11M | Sell |
79,891
-296,427
| -79% | -$28M | 0.34% | 77 |
|
|
2016
Q2 | $36M | Sell |
376,318
-15,101
| -4% | -$1.5M | 1.6% | 9 |
|
|
2016
Q1 | $40.6M | Buy |
391,419
+355,272
| +983% | +$34.5M | 1.83% | 5 |
|
|
2015
Q4 | $36.1K | Sell |
36,147
-359,203
| -91% | -$35.2M | 1.76% | 9 |
|
|
2015
Q3 | $38.1M | Buy |
395,350
+2,755
| +0.7% | +$290K | 1.8% | 7 |
|
|
2015
Q2 | $41.2M | Buy |
392,595
+765
| +0.2% | +$78.2K | 1.93% | 4 |
|
|
2015
Q1 | $40.4M | Sell |
391,830
-171,013
| -30% | -$17.3M | 1.97% | 4 |
|
|
2014
Q4 | $54.2M | Buy |
562,843
+157,398
| +39% | +$13.9M | 2.19% | 3 |
|
|
2014
Q3 | $32.3M | Buy |
405,445
+123
| +0% | +$9.7K | 1.87% | 4 |
|
|
2014
Q2 | $30.5M | Sell |
405,322
-3,007
| -0.7% | -$227K | 1.79% | 7 |
|
|
2014
Q1 | $30.6M | Sell |
408,329
-13,431
| -3% | -$949K | 1.92% | 1 |
|
|
2013
Q4 | $30.2M | Sell |
421,760
-7,951
| -2% | -$511K | 1.94% | 3 |
|
|
2013
Q3 | $24.4M | Buy |
429,711
+4,500
| +1% | +$268K | 1.75% | 6 |
|
|
2013
Q2 | $24.3M | Buy |
+425,211
| New | +$24.6M | 1.84% | 2 |
|
Other funds holding CVS
Dana Investment Advisors's CVS Position: Q3 2024 in Review
Dana Investment Advisors sold out of CVS Health (CVS) in Q3 2024, closing a stake of 138,114 shares — an estimated $8.16M sold.
Dana Investment Advisors first reported a position in CVS in Q2 2013 and held it in 42 quarters. The position peaked at $54.2M in Q4 2014. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.
- Dana Investment Advisors reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
- Dana Investment Advisors sold 138,114 CVS Health shares in Q3 2024, an estimated $8.16M.
- Dana Investment Advisors first reported a position in CVS Health in Q2 2013 and held it in 42 quarters.
- Dana Investment Advisors's CVS Health position peaked at $54.2M in Q4 2014.
- 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.
Based on Dana Investment Advisors's 13F filing for Q3 2024, filed 13 Nov 2024.